Table 1 Clinical characteristics of GC patients according to GLT8D1 expression
Characteristic | Low expression of GLT8D1 | High expression of GLT8D1 | P |
|---|---|---|---|
n | 187 | 188 | Â |
Gender, n (%) | Â | Â | 0.884 |
Female | 68 (18.1%) | 66 (17.6%) | Â |
Male | 119 (31.7%) | 122 (32.5%) | Â |
T stage, n (%) | Â | Â | 0.111 |
T1 | 14 (3.8%) | 5 (1.4%) | Â |
T2 | 40 (10.9%) | 40 (10.9%) | Â |
T3 | 88 (24%) | 80 (21.8%) | Â |
T4 | 44 (12%) | 56 (15.3%) | Â |
N stage, n (%) | Â | Â | 0.189 |
N0 | 63 (17.6%) | 48 (13.4%) | Â |
N1 | 48 (13.4%) | 49 (13.7%) | Â |
N2 | 39 (10.9%) | 36 (10.1%) | Â |
N3 | 30 (8.4%) | 44 (12.3%) | Â |
M stage, n (%) | Â | Â | 0.253 |
M0 | 165 (46.5%) | 165 (46.5%) | Â |
M1 | 9 (2.5%) | 16 (4.5%) | Â |
Pathologic stage, n (%) | Â | Â | 0.032 |
Stage I | 32 (9.1%) | 21 (6%) | Â |
Stage II | 64 (18.2%) | 47 (13.4%) | Â |
Stage III | 68 (19.3%) | 82 (23.3%) | Â |
Stage IV | 14 (4%) | 24 (6.8%) | Â |
H. pylori infection, n (%) |  |  | 0.781 |
No | 71 (43.6%) | 74 (45.4%) | Â |
Yes | 10 (6.1%) | 8 (4.9%) | Â |
Histologic grade, n (%) | Â | Â | 0.808 |
G1 | 4 (1.1%) | 6 (1.6%) | Â |
G2 | 70 (19.1%) | 67 (18.3%) | Â |
G3 | 109 (29.8%) | 110 (30.1%) | Â |
Residual tumor, n (%) | Â | Â | 0.173 |
R0 | 158 (48%) | 140 (42.6%) | Â |
R1 | 5 (1.5%) | 10 (3%) | Â |
R2 | 6 (1.8%) | 10 (3%) | Â |
OS event, n (%) |  |  | < 0.001 |
Alive | 132 (35.2%) | 96 (25.6%) | Â |
Dead | 55 (14.7%) | 92 (24.5%) | Â |
DSS event, n (%) | Â | Â | 0.003 |
Alive | 147 (41.5%) | 116 (32.8%) | Â |
Dead | 34 (9.6%) | 57 (16.1%) | Â |
Age, n (%) | Â | Â | 0.032 |
<=65 | 93 (25.1%) | 71 (19.1%) | Â |
> 65 | 93 (25.1%) | 114 (30.7%) |  |